Albany Molecular Research, Inc. AMRI
Set alert
21.74 0.00 0.00%
At close · Jun 28
21.73 Day range 21.76
13.01 52-week range 22.17
- Open
- 21.74
- Prev close
- 21.74
- Mkt cap
- 0
- Vol
- 531.22K
- Avg vol
- 655.55K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.73
- High
- 21.76
- Forward P/E
- 17.67
- Beta
- 0.59
- Short ratio
- 8.49
- Inst. own
- 97.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 17, 2017
- 50-d avg
- 21.73
- 200-d avg
- 19.09
- 1y target
- 10.70
Analyst view
Consensus: hold
Hold
Price target (mean) 10.70
Recommendation trend
- 1 month ago 3
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.36 | 0.0% | 172.93M | +43.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.17 | 0.0% | 170.16M | +11.4% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 720.13M | +26.2% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 771.60M | +7.1% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 7, 2017 | JP Morgan | Downgrade | — | Neutral |
| May 10, 2017 | Morgan Stanley | Downgrade | — | Equal-Weight |
| Oct 25, 2015 | First Analysis | Upgrade | — | Overweight |
| Dec 17, 2014 | First Analysis | Initiated | — | Equal-Weight |
| Sep 8, 2014 | JP Morgan | Initiated | — | Overweight |
| Apr 8, 2014 | Morgan Stanley | Initiated | — | Overweight |
| Dec 2, 2013 | Sterne Agee | Downgrade | — | Neutral |
| Jun 10, 2013 | Sterne Agee | Initiated | — | Buy |